nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—HTR1A—stomach cancer	0.33	1	CbGaD
Sumatriptan—ABCB1—Mitomycin—stomach cancer	0.0591	0.159	CbGbCtD
Sumatriptan—SLCO1B1—Irinotecan—stomach cancer	0.0529	0.143	CbGbCtD
Sumatriptan—ABCG2—Irinotecan—stomach cancer	0.042	0.113	CbGbCtD
Sumatriptan—ABCG2—Fluorouracil—stomach cancer	0.0403	0.109	CbGbCtD
Sumatriptan—ABCG2—Docetaxel—stomach cancer	0.0308	0.0831	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—stomach cancer	0.0297	0.0801	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—stomach cancer	0.028	0.0755	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—stomach cancer	0.023	0.062	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—stomach cancer	0.0222	0.06	CbGbCtD
Sumatriptan—ABCB1—Irinotecan—stomach cancer	0.0152	0.0409	CbGbCtD
Sumatriptan—HTR3A—myenteric nerve plexus—stomach cancer	0.0119	0.284	CbGeAlD
Sumatriptan—ABCB1—Docetaxel—stomach cancer	0.0111	0.03	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—stomach cancer	0.00828	0.0223	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—stomach cancer	0.00802	0.0216	CbGbCtD
Sumatriptan—HTR3A—vagus nerve—stomach cancer	0.00791	0.189	CbGeAlD
Sumatriptan—HTR1B—blood vessel—stomach cancer	0.00203	0.0487	CbGeAlD
Sumatriptan—HTR1D—blood vessel—stomach cancer	0.00197	0.0471	CbGeAlD
Sumatriptan—HTR3A—hematopoietic system—stomach cancer	0.00129	0.0309	CbGeAlD
Sumatriptan—SLCO1B1—hematopoietic system—stomach cancer	0.00125	0.03	CbGeAlD
Sumatriptan—Naratriptan—HTR1A—stomach cancer	0.00104	0.282	CrCbGaD
Sumatriptan—SLCO1A2—hematopoietic system—stomach cancer	0.00102	0.0244	CbGeAlD
Sumatriptan—HTR3A—digestive system—stomach cancer	0.000898	0.0215	CbGeAlD
Sumatriptan—HTR1A—hematopoietic system—stomach cancer	0.000874	0.0209	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—stomach cancer	0.000871	0.0208	CbGeAlD
Sumatriptan—Rizatriptan—HTR1A—stomach cancer	0.00086	0.234	CrCbGaD
Sumatriptan—MAOA—hematopoietic system—stomach cancer	0.000799	0.0191	CbGeAlD
Sumatriptan—Zolmitriptan—HTR1A—stomach cancer	0.000787	0.214	CrCbGaD
Sumatriptan—SLCO1B1—endocrine gland—stomach cancer	0.00072	0.0172	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—stomach cancer	0.000709	0.017	CbGeAlD
Sumatriptan—MAOA—pancreas—stomach cancer	0.00065	0.0156	CbGeAlD
Sumatriptan—SLCO1B1—liver—stomach cancer	0.000649	0.0155	CbGeAlD
Sumatriptan—ABCB1—blood vessel—stomach cancer	0.000641	0.0153	CbGeAlD
Sumatriptan—HTR1B—endocrine gland—stomach cancer	0.000622	0.0149	CbGeAlD
Sumatriptan—SLCO1A2—endocrine gland—stomach cancer	0.000586	0.014	CbGeAlD
Sumatriptan—MAOA—digestive system—stomach cancer	0.000555	0.0133	CbGeAlD
Sumatriptan—Eletriptan—CYP2A6—stomach cancer	0.000535	0.145	CrCbGaD
Sumatriptan—SLCO1A2—liver—stomach cancer	0.000528	0.0126	CbGeAlD
Sumatriptan—HTR1A—endocrine gland—stomach cancer	0.000502	0.012	CbGeAlD
Sumatriptan—Eletriptan—HTR1A—stomach cancer	0.000465	0.126	CrCbGaD
Sumatriptan—MAOA—endocrine gland—stomach cancer	0.000459	0.011	CbGeAlD
Sumatriptan—DRD2—endocrine gland—stomach cancer	0.000454	0.0109	CbGeAlD
Sumatriptan—ABCG2—bone marrow—stomach cancer	0.000444	0.0106	CbGeAlD
Sumatriptan—MAOA—liver—stomach cancer	0.000414	0.0099	CbGeAlD
Sumatriptan—ABCG2—liver—stomach cancer	0.000359	0.00858	CbGeAlD
Sumatriptan—ABCB1—hematopoietic system—stomach cancer	0.000341	0.00817	CbGeAlD
Sumatriptan—MAOA—lymph node—stomach cancer	0.000317	0.00759	CbGeAlD
Sumatriptan—ABCB1—epithelium—stomach cancer	0.000312	0.00747	CbGeAlD
Sumatriptan—ABCB1—pancreas—stomach cancer	0.000278	0.00665	CbGeAlD
Sumatriptan—ABCG2—lymph node—stomach cancer	0.000275	0.00658	CbGeAlD
Sumatriptan—ABCB1—lymphoid tissue—stomach cancer	0.00024	0.00575	CbGeAlD
Sumatriptan—ABCB1—digestive system—stomach cancer	0.000237	0.00568	CbGeAlD
Sumatriptan—ABCB1—bone marrow—stomach cancer	0.000219	0.00524	CbGeAlD
Sumatriptan—ABCB1—endocrine gland—stomach cancer	0.000196	0.00469	CbGeAlD
Sumatriptan—ABCB1—liver—stomach cancer	0.000177	0.00423	CbGeAlD
Sumatriptan—ABCB1—lymph node—stomach cancer	0.000136	0.00324	CbGeAlD
Sumatriptan—Sweating—Doxorubicin—stomach cancer	7.09e-05	0.000371	CcSEcCtD
Sumatriptan—Hyperhidrosis—Capecitabine—stomach cancer	7.07e-05	0.000371	CcSEcCtD
Sumatriptan—Hypotension—Docetaxel—stomach cancer	7.06e-05	0.00037	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—stomach cancer	7.05e-05	0.000369	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—stomach cancer	7.05e-05	0.000369	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—stomach cancer	6.97e-05	0.000365	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—stomach cancer	6.95e-05	0.000364	CcSEcCtD
Sumatriptan—Vomiting—Irinotecan—stomach cancer	6.95e-05	0.000364	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—stomach cancer	6.93e-05	0.000363	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—stomach cancer	6.92e-05	0.000363	CcSEcCtD
Sumatriptan—Dizziness—Fluorouracil—stomach cancer	6.92e-05	0.000363	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—stomach cancer	6.91e-05	0.000362	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—stomach cancer	6.91e-05	0.000362	CcSEcCtD
Sumatriptan—Rash—Irinotecan—stomach cancer	6.89e-05	0.000361	CcSEcCtD
Sumatriptan—Dermatitis—Irinotecan—stomach cancer	6.88e-05	0.000361	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.88e-05	0.000361	CcSEcCtD
Sumatriptan—Chills—Methotrexate—stomach cancer	6.88e-05	0.00036	CcSEcCtD
Sumatriptan—Headache—Irinotecan—stomach cancer	6.85e-05	0.000359	CcSEcCtD
Sumatriptan—Hypotension—Capecitabine—stomach cancer	6.83e-05	0.000358	CcSEcCtD
Sumatriptan—Paraesthesia—Docetaxel—stomach cancer	6.78e-05	0.000355	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—stomach cancer	6.75e-05	0.000354	CcSEcCtD
Sumatriptan—Dyspnoea—Docetaxel—stomach cancer	6.73e-05	0.000353	CcSEcCtD
Sumatriptan—Somnolence—Docetaxel—stomach cancer	6.71e-05	0.000352	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—stomach cancer	6.7e-05	0.000351	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—stomach cancer	6.69e-05	0.00035	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—stomach cancer	6.67e-05	0.00035	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—stomach cancer	6.67e-05	0.00035	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.66e-05	0.000349	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—stomach cancer	6.66e-05	0.000349	CcSEcCtD
Sumatriptan—Vomiting—Fluorouracil—stomach cancer	6.65e-05	0.000349	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—stomach cancer	6.64e-05	0.000348	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—stomach cancer	6.6e-05	0.000346	CcSEcCtD
Sumatriptan—Rash—Fluorouracil—stomach cancer	6.6e-05	0.000346	CcSEcCtD
Sumatriptan—Dermatitis—Fluorouracil—stomach cancer	6.59e-05	0.000345	CcSEcCtD
Sumatriptan—Paraesthesia—Capecitabine—stomach cancer	6.57e-05	0.000344	CcSEcCtD
Sumatriptan—Decreased appetite—Docetaxel—stomach cancer	6.57e-05	0.000344	CcSEcCtD
Sumatriptan—Headache—Fluorouracil—stomach cancer	6.56e-05	0.000344	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—stomach cancer	6.53e-05	0.000342	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Docetaxel—stomach cancer	6.52e-05	0.000342	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—stomach cancer	6.52e-05	0.000342	CcSEcCtD
Sumatriptan—Dyspnoea—Capecitabine—stomach cancer	6.52e-05	0.000342	CcSEcCtD
Sumatriptan—Fatigue—Docetaxel—stomach cancer	6.51e-05	0.000341	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—stomach cancer	6.51e-05	0.000341	CcSEcCtD
Sumatriptan—Nausea—Irinotecan—stomach cancer	6.49e-05	0.00034	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—stomach cancer	6.48e-05	0.000339	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—stomach cancer	6.46e-05	0.000339	CcSEcCtD
Sumatriptan—Pain—Docetaxel—stomach cancer	6.46e-05	0.000339	CcSEcCtD
Sumatriptan—Constipation—Docetaxel—stomach cancer	6.46e-05	0.000339	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—stomach cancer	6.45e-05	0.000338	CcSEcCtD
Sumatriptan—Chills—Epirubicin—stomach cancer	6.43e-05	0.000337	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—stomach cancer	6.41e-05	0.000336	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—stomach cancer	6.39e-05	0.000335	CcSEcCtD
Sumatriptan—Decreased appetite—Capecitabine—stomach cancer	6.36e-05	0.000333	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Capecitabine—stomach cancer	6.31e-05	0.000331	CcSEcCtD
Sumatriptan—Fatigue—Capecitabine—stomach cancer	6.3e-05	0.00033	CcSEcCtD
Sumatriptan—Constipation—Capecitabine—stomach cancer	6.25e-05	0.000328	CcSEcCtD
Sumatriptan—Pain—Capecitabine—stomach cancer	6.25e-05	0.000328	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—stomach cancer	6.24e-05	0.000327	CcSEcCtD
Sumatriptan—Feeling abnormal—Docetaxel—stomach cancer	6.22e-05	0.000326	CcSEcCtD
Sumatriptan—Nausea—Fluorouracil—stomach cancer	6.22e-05	0.000326	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—stomach cancer	6.2e-05	0.000325	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—stomach cancer	6.19e-05	0.000324	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—stomach cancer	6.19e-05	0.000324	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Docetaxel—stomach cancer	6.18e-05	0.000324	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—stomach cancer	6.17e-05	0.000323	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—stomach cancer	6.16e-05	0.000323	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—stomach cancer	6.15e-05	0.000322	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—stomach cancer	6.11e-05	0.00032	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—stomach cancer	6.04e-05	0.000316	CcSEcCtD
Sumatriptan—Feeling abnormal—Capecitabine—stomach cancer	6.03e-05	0.000316	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—stomach cancer	6.02e-05	0.000315	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—stomach cancer	6.02e-05	0.000315	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—stomach cancer	6e-05	0.000315	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—stomach cancer	5.99e-05	0.000314	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—stomach cancer	5.99e-05	0.000314	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Capecitabine—stomach cancer	5.98e-05	0.000313	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—stomach cancer	5.98e-05	0.000313	CcSEcCtD
Sumatriptan—Abdominal pain—Docetaxel—stomach cancer	5.97e-05	0.000313	CcSEcCtD
Sumatriptan—Body temperature increased—Docetaxel—stomach cancer	5.97e-05	0.000313	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—stomach cancer	5.95e-05	0.000312	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—stomach cancer	5.93e-05	0.000311	CcSEcCtD
Sumatriptan—Cough—Methotrexate—stomach cancer	5.82e-05	0.000305	CcSEcCtD
Sumatriptan—Urticaria—Capecitabine—stomach cancer	5.81e-05	0.000304	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—stomach cancer	5.79e-05	0.000304	CcSEcCtD
Sumatriptan—Abdominal pain—Capecitabine—stomach cancer	5.78e-05	0.000303	CcSEcCtD
Sumatriptan—Body temperature increased—Capecitabine—stomach cancer	5.78e-05	0.000303	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—stomach cancer	5.78e-05	0.000303	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—stomach cancer	5.78e-05	0.000303	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—stomach cancer	5.77e-05	0.000302	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—stomach cancer	5.74e-05	0.000301	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—stomach cancer	5.69e-05	0.000298	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—stomach cancer	5.68e-05	0.000298	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—stomach cancer	5.68e-05	0.000298	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—stomach cancer	5.68e-05	0.000298	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—stomach cancer	5.66e-05	0.000296	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—stomach cancer	5.63e-05	0.000295	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—stomach cancer	5.61e-05	0.000294	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—stomach cancer	5.61e-05	0.000294	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—stomach cancer	5.6e-05	0.000293	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—stomach cancer	5.59e-05	0.000293	CcSEcCtD
Sumatriptan—Hypersensitivity—Docetaxel—stomach cancer	5.56e-05	0.000292	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—stomach cancer	5.55e-05	0.000291	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—stomach cancer	5.52e-05	0.000289	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—stomach cancer	5.49e-05	0.000288	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—stomach cancer	5.49e-05	0.000288	CcSEcCtD
Sumatriptan—Cough—Epirubicin—stomach cancer	5.45e-05	0.000285	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—stomach cancer	5.44e-05	0.000285	CcSEcCtD
Sumatriptan—Asthenia—Docetaxel—stomach cancer	5.42e-05	0.000284	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—stomach cancer	5.41e-05	0.000283	CcSEcCtD
Sumatriptan—Infection—Methotrexate—stomach cancer	5.41e-05	0.000283	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—stomach cancer	5.39e-05	0.000282	CcSEcCtD
Sumatriptan—Hypersensitivity—Capecitabine—stomach cancer	5.39e-05	0.000282	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—stomach cancer	5.36e-05	0.000281	CcSEcCtD
Sumatriptan—Pruritus—Docetaxel—stomach cancer	5.34e-05	0.00028	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—stomach cancer	5.34e-05	0.00028	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—stomach cancer	5.34e-05	0.00028	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—stomach cancer	5.33e-05	0.000279	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—stomach cancer	5.31e-05	0.000279	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—stomach cancer	5.31e-05	0.000279	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—stomach cancer	5.31e-05	0.000279	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—stomach cancer	5.31e-05	0.000278	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—stomach cancer	5.3e-05	0.000278	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—stomach cancer	5.29e-05	0.000277	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—stomach cancer	5.26e-05	0.000276	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—stomach cancer	5.25e-05	0.000275	CcSEcCtD
Sumatriptan—Asthenia—Capecitabine—stomach cancer	5.25e-05	0.000275	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—stomach cancer	5.21e-05	0.000273	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—stomach cancer	5.2e-05	0.000272	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—stomach cancer	5.19e-05	0.000272	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—stomach cancer	5.18e-05	0.000271	CcSEcCtD
Sumatriptan—Pruritus—Capecitabine—stomach cancer	5.17e-05	0.000271	CcSEcCtD
Sumatriptan—Diarrhoea—Docetaxel—stomach cancer	5.17e-05	0.000271	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—stomach cancer	5.14e-05	0.000269	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—stomach cancer	5.1e-05	0.000268	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—stomach cancer	5.09e-05	0.000267	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—stomach cancer	5.09e-05	0.000267	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—stomach cancer	5.09e-05	0.000267	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—stomach cancer	5.08e-05	0.000266	CcSEcCtD
Sumatriptan—Infection—Epirubicin—stomach cancer	5.06e-05	0.000265	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—stomach cancer	5.04e-05	0.000264	CcSEcCtD
Sumatriptan—Shock—Epirubicin—stomach cancer	5.01e-05	0.000263	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—stomach cancer	5e-05	0.000262	CcSEcCtD
Sumatriptan—Diarrhoea—Capecitabine—stomach cancer	5e-05	0.000262	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—stomach cancer	5e-05	0.000262	CcSEcCtD
Sumatriptan—Dizziness—Docetaxel—stomach cancer	4.99e-05	0.000262	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—stomach cancer	4.99e-05	0.000261	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—stomach cancer	4.99e-05	0.000261	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—stomach cancer	4.97e-05	0.000261	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.96e-05	0.00026	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—stomach cancer	4.95e-05	0.000259	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—stomach cancer	4.93e-05	0.000258	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—stomach cancer	4.92e-05	0.000258	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—stomach cancer	4.92e-05	0.000258	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—stomach cancer	4.92e-05	0.000258	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—stomach cancer	4.9e-05	0.000257	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—stomach cancer	4.89e-05	0.000256	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—stomach cancer	4.86e-05	0.000255	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—stomach cancer	4.85e-05	0.000254	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—stomach cancer	4.84e-05	0.000254	CcSEcCtD
Sumatriptan—Dizziness—Capecitabine—stomach cancer	4.84e-05	0.000253	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—stomach cancer	4.81e-05	0.000252	CcSEcCtD
Sumatriptan—Vomiting—Docetaxel—stomach cancer	4.8e-05	0.000252	CcSEcCtD
Sumatriptan—Rash—Docetaxel—stomach cancer	4.76e-05	0.00025	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—stomach cancer	4.76e-05	0.000249	CcSEcCtD
Sumatriptan—Dermatitis—Docetaxel—stomach cancer	4.76e-05	0.000249	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—stomach cancer	4.75e-05	0.000249	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—stomach cancer	4.73e-05	0.000248	CcSEcCtD
Sumatriptan—Headache—Docetaxel—stomach cancer	4.73e-05	0.000248	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—stomach cancer	4.71e-05	0.000247	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—stomach cancer	4.71e-05	0.000247	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—stomach cancer	4.7e-05	0.000246	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—stomach cancer	4.69e-05	0.000246	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—stomach cancer	4.68e-05	0.000245	CcSEcCtD
Sumatriptan—Pain—Methotrexate—stomach cancer	4.66e-05	0.000244	CcSEcCtD
Sumatriptan—Vomiting—Capecitabine—stomach cancer	4.65e-05	0.000244	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.64e-05	0.000243	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—stomach cancer	4.64e-05	0.000243	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—stomach cancer	4.62e-05	0.000242	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—stomach cancer	4.62e-05	0.000242	CcSEcCtD
Sumatriptan—Rash—Capecitabine—stomach cancer	4.61e-05	0.000242	CcSEcCtD
Sumatriptan—Dermatitis—Capecitabine—stomach cancer	4.61e-05	0.000241	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—stomach cancer	4.6e-05	0.000241	CcSEcCtD
Sumatriptan—Headache—Capecitabine—stomach cancer	4.58e-05	0.00024	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—stomach cancer	4.58e-05	0.00024	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—stomach cancer	4.57e-05	0.00024	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—stomach cancer	4.56e-05	0.000239	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—stomach cancer	4.54e-05	0.000238	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—stomach cancer	4.53e-05	0.000237	CcSEcCtD
Sumatriptan—Nausea—Docetaxel—stomach cancer	4.49e-05	0.000235	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—stomach cancer	4.49e-05	0.000235	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—stomach cancer	4.45e-05	0.000233	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—stomach cancer	4.43e-05	0.000232	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—stomach cancer	4.4e-05	0.000231	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—stomach cancer	4.4e-05	0.000231	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—stomach cancer	4.39e-05	0.00023	CcSEcCtD
Sumatriptan—Pain—Epirubicin—stomach cancer	4.36e-05	0.000228	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—stomach cancer	4.36e-05	0.000228	CcSEcCtD
Sumatriptan—Nausea—Capecitabine—stomach cancer	4.34e-05	0.000228	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—stomach cancer	4.32e-05	0.000227	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—stomach cancer	4.3e-05	0.000226	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—stomach cancer	4.3e-05	0.000226	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.29e-05	0.000225	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—stomach cancer	4.23e-05	0.000222	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—stomach cancer	4.2e-05	0.00022	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—stomach cancer	4.2e-05	0.00022	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—stomach cancer	4.19e-05	0.00022	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—stomach cancer	4.17e-05	0.000218	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—stomach cancer	4.1e-05	0.000215	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.07e-05	0.000213	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—stomach cancer	4.06e-05	0.000213	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—stomach cancer	4.05e-05	0.000212	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—stomach cancer	4.03e-05	0.000211	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—stomach cancer	4.03e-05	0.000211	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—stomach cancer	4.03e-05	0.000211	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—stomach cancer	4.03e-05	0.000211	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—stomach cancer	4.01e-05	0.00021	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—stomach cancer	3.91e-05	0.000205	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—stomach cancer	3.88e-05	0.000204	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—stomach cancer	3.85e-05	0.000202	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—stomach cancer	3.85e-05	0.000202	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—stomach cancer	3.75e-05	0.000197	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—stomach cancer	3.74e-05	0.000196	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—stomach cancer	3.73e-05	0.000195	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—stomach cancer	3.73e-05	0.000195	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—stomach cancer	3.72e-05	0.000195	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—stomach cancer	3.66e-05	0.000192	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—stomach cancer	3.6e-05	0.000189	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—stomach cancer	3.6e-05	0.000189	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—stomach cancer	3.49e-05	0.000183	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—stomach cancer	3.47e-05	0.000182	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—stomach cancer	3.46e-05	0.000181	CcSEcCtD
Sumatriptan—Rash—Methotrexate—stomach cancer	3.43e-05	0.00018	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—stomach cancer	3.43e-05	0.00018	CcSEcCtD
Sumatriptan—Headache—Methotrexate—stomach cancer	3.41e-05	0.000179	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—stomach cancer	3.38e-05	0.000177	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—stomach cancer	3.37e-05	0.000177	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—stomach cancer	3.34e-05	0.000175	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—stomach cancer	3.24e-05	0.00017	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—stomach cancer	3.23e-05	0.000169	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—stomach cancer	3.23e-05	0.000169	CcSEcCtD
Sumatriptan—Rash—Epirubicin—stomach cancer	3.21e-05	0.000168	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—stomach cancer	3.21e-05	0.000168	CcSEcCtD
Sumatriptan—Headache—Epirubicin—stomach cancer	3.19e-05	0.000167	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—stomach cancer	3.12e-05	0.000163	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—stomach cancer	3.03e-05	0.000159	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—stomach cancer	3e-05	0.000157	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—stomach cancer	2.97e-05	0.000156	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—stomach cancer	2.97e-05	0.000156	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—stomach cancer	2.95e-05	0.000155	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—stomach cancer	2.8e-05	0.000147	CcSEcCtD
Sumatriptan—HTR1F—Signaling Pathways—ERBB2—stomach cancer	9.14e-06	0.000144	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGFR2—stomach cancer	9.12e-06	0.000144	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—stomach cancer	9.1e-06	0.000144	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.95e-06	0.000141	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALOX5—stomach cancer	8.87e-06	0.00014	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.87e-06	0.00014	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPS6—stomach cancer	8.87e-06	0.00014	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6R—stomach cancer	8.83e-06	0.000139	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	8.78e-06	0.000139	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DPYD—stomach cancer	8.73e-06	0.000138	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKCB—stomach cancer	8.72e-06	0.000138	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6ST—stomach cancer	8.69e-06	0.000137	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—stomach cancer	8.68e-06	0.000137	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CAV1—stomach cancer	8.68e-06	0.000137	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—stomach cancer	8.67e-06	0.000137	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOA1—stomach cancer	8.66e-06	0.000137	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HRAS—stomach cancer	8.62e-06	0.000136	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB2—stomach cancer	8.57e-06	0.000135	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ERCC2—stomach cancer	8.55e-06	0.000135	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	8.54e-06	0.000135	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IRS2—stomach cancer	8.53e-06	0.000135	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1B—stomach cancer	8.47e-06	0.000134	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	8.39e-06	0.000133	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IRS2—stomach cancer	8.35e-06	0.000132	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CAV1—stomach cancer	8.27e-06	0.000131	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOA1—stomach cancer	8.25e-06	0.00013	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—stomach cancer	8.25e-06	0.00013	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—stomach cancer	8.23e-06	0.00013	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HBEGF—stomach cancer	8.15e-06	0.000129	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CAV1—stomach cancer	8.1e-06	0.000128	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—stomach cancer	8.08e-06	0.000128	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOA1—stomach cancer	8.08e-06	0.000128	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JUN—stomach cancer	8.06e-06	0.000127	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—stomach cancer	8.04e-06	0.000127	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAV1—stomach cancer	8.01e-06	0.000126	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOA1—stomach cancer	7.99e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RHOA—stomach cancer	7.98e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKCB—stomach cancer	7.87e-06	0.000124	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—stomach cancer	7.84e-06	0.000124	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6ST—stomach cancer	7.84e-06	0.000124	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1A—stomach cancer	7.82e-06	0.000123	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SMAD4—stomach cancer	7.79e-06	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6R—stomach cancer	7.75e-06	0.000122	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—stomach cancer	7.72e-06	0.000122	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RHOA—stomach cancer	7.71e-06	0.000122	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	7.71e-06	0.000122	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKCB—stomach cancer	7.71e-06	0.000122	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6ST—stomach cancer	7.68e-06	0.000121	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.65e-06	0.000121	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2A6—stomach cancer	7.63e-06	0.00012	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK8—stomach cancer	7.63e-06	0.00012	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—stomach cancer	7.63e-06	0.00012	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APC—stomach cancer	7.53e-06	0.000119	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB2—stomach cancer	7.52e-06	0.000119	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKR1C3—stomach cancer	7.42e-06	0.000117	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAV1—stomach cancer	7.41e-06	0.000117	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—stomach cancer	7.4e-06	0.000117	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FYN—stomach cancer	7.4e-06	0.000117	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOA1—stomach cancer	7.4e-06	0.000117	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APC—stomach cancer	7.37e-06	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	7.37e-06	0.000116	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ENO1—stomach cancer	7.23e-06	0.000114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK3—stomach cancer	7.21e-06	0.000114	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—stomach cancer	7.08e-06	0.000112	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK3—stomach cancer	7.06e-06	0.000112	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—stomach cancer	7.04e-06	0.000111	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—stomach cancer	7.04e-06	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RHOA—stomach cancer	7e-06	0.000111	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	7e-06	0.000111	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6R—stomach cancer	6.99e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—stomach cancer	6.97e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGFR2—stomach cancer	6.95e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK1—stomach cancer	6.86e-06	0.000108	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—stomach cancer	6.86e-06	0.000108	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—stomach cancer	6.86e-06	0.000108	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6R—stomach cancer	6.85e-06	0.000108	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SMAD4—stomach cancer	6.84e-06	0.000108	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	6.77e-06	0.000107	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.77e-06	0.000107	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK1—stomach cancer	6.72e-06	0.000106	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—stomach cancer	6.72e-06	0.000106	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK3—stomach cancer	6.66e-06	0.000105	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—stomach cancer	6.56e-06	0.000104	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—stomach cancer	6.56e-06	0.000104	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—stomach cancer	6.55e-06	0.000103	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—stomach cancer	6.52e-06	0.000103	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FYN—stomach cancer	6.5e-06	0.000103	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—stomach cancer	6.48e-06	0.000102	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—stomach cancer	6.48e-06	0.000102	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—stomach cancer	6.48e-06	0.000102	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—stomach cancer	6.42e-06	0.000101	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD44—stomach cancer	6.42e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—stomach cancer	6.41e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IRS2—stomach cancer	6.36e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—stomach cancer	6.35e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK1—stomach cancer	6.34e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—stomach cancer	6.34e-06	0.0001	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—stomach cancer	6.33e-06	9.99e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RHOA—stomach cancer	6.32e-06	9.97e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—stomach cancer	6.25e-06	9.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RHOA—stomach cancer	6.19e-06	9.77e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CAV1—stomach cancer	6.17e-06	9.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOA1—stomach cancer	6.15e-06	9.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—stomach cancer	6.15e-06	9.71e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—stomach cancer	6.12e-06	9.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR2—stomach cancer	6.1e-06	9.63e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—stomach cancer	6.05e-06	9.56e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—stomach cancer	6e-06	9.47e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—stomach cancer	5.99e-06	9.45e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—stomach cancer	5.96e-06	9.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCB—stomach cancer	5.87e-06	9.27e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—stomach cancer	5.86e-06	9.25e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—stomach cancer	5.85e-06	9.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6ST—stomach cancer	5.85e-06	9.23e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	5.83e-06	9.21e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—stomach cancer	5.73e-06	9.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—stomach cancer	5.62e-06	8.87e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—stomach cancer	5.61e-06	8.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IRS2—stomach cancer	5.58e-06	8.82e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—stomach cancer	5.55e-06	8.76e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—stomach cancer	5.54e-06	8.74e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—stomach cancer	5.51e-06	8.7e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—stomach cancer	5.5e-06	8.69e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.46e-06	8.61e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—stomach cancer	5.43e-06	8.57e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	5.42e-06	8.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CAV1—stomach cancer	5.42e-06	8.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOA1—stomach cancer	5.4e-06	8.53e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—stomach cancer	5.4e-06	8.52e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	5.38e-06	8.49e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—stomach cancer	5.35e-06	8.45e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—stomach cancer	5.32e-06	8.4e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	5.3e-06	8.37e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—stomach cancer	5.28e-06	8.33e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—stomach cancer	5.27e-06	8.33e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6R—stomach cancer	5.22e-06	8.24e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—stomach cancer	5.17e-06	8.16e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—stomach cancer	5.16e-06	8.15e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—stomach cancer	5.16e-06	8.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCB—stomach cancer	5.15e-06	8.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6ST—stomach cancer	5.13e-06	8.11e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—stomach cancer	5.13e-06	8.1e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	5.12e-06	8.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—stomach cancer	5.12e-06	8.08e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—stomach cancer	5.09e-06	8.04e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—stomach cancer	5.06e-06	7.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—stomach cancer	5.05e-06	7.97e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—stomach cancer	5.02e-06	7.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	5e-06	7.89e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMS—stomach cancer	4.97e-06	7.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—stomach cancer	4.93e-06	7.79e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—stomach cancer	4.92e-06	7.76e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—stomach cancer	4.91e-06	7.76e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	4.89e-06	7.73e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.89e-06	7.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	4.88e-06	7.71e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—stomach cancer	4.88e-06	7.7e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—stomach cancer	4.87e-06	7.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—stomach cancer	4.84e-06	7.63e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—stomach cancer	4.78e-06	7.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK3—stomach cancer	4.72e-06	7.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RHOA—stomach cancer	4.71e-06	7.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—stomach cancer	4.66e-06	7.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ERCC2—stomach cancer	4.62e-06	7.3e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6R—stomach cancer	4.58e-06	7.23e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—stomach cancer	4.5e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK1—stomach cancer	4.49e-06	7.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—stomach cancer	4.49e-06	7.1e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—stomach cancer	4.46e-06	7.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	4.44e-06	7.01e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—stomach cancer	4.41e-06	6.96e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—stomach cancer	4.37e-06	6.9e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—stomach cancer	4.36e-06	6.89e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—stomach cancer	4.35e-06	6.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	4.29e-06	6.78e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—stomach cancer	4.29e-06	6.77e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK3—stomach cancer	4.26e-06	6.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—stomach cancer	4.25e-06	6.7e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK3—stomach cancer	4.17e-06	6.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—stomach cancer	4.14e-06	6.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RHOA—stomach cancer	4.14e-06	6.53e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—stomach cancer	4.14e-06	6.53e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—stomach cancer	4.11e-06	6.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—stomach cancer	4.09e-06	6.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—stomach cancer	4.06e-06	6.41e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK1—stomach cancer	4.05e-06	6.4e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—stomach cancer	4.05e-06	6.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	4.04e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAV1—stomach cancer	4.01e-06	6.33e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOA1—stomach cancer	4e-06	6.32e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—stomach cancer	3.98e-06	6.29e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK1—stomach cancer	3.97e-06	6.27e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—stomach cancer	3.97e-06	6.27e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.93e-06	6.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	3.9e-06	6.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—stomach cancer	3.85e-06	6.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—stomach cancer	3.85e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—stomach cancer	3.83e-06	6.05e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—stomach cancer	3.83e-06	6.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.75e-06	5.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.74e-06	5.91e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.73e-06	5.89e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—stomach cancer	3.69e-06	5.83e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—stomach cancer	3.64e-06	5.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—stomach cancer	3.63e-06	5.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—stomach cancer	3.61e-06	5.7e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—stomach cancer	3.55e-06	5.6e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—stomach cancer	3.52e-06	5.56e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	3.52e-06	5.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—stomach cancer	3.45e-06	5.45e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	3.44e-06	5.44e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—stomach cancer	3.41e-06	5.38e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—stomach cancer	3.4e-06	5.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—stomach cancer	3.38e-06	5.34e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—stomach cancer	3.38e-06	5.33e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.36e-06	5.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—stomach cancer	3.33e-06	5.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.33e-06	5.25e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—stomach cancer	3.29e-06	5.19e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—stomach cancer	3.27e-06	5.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—stomach cancer	3.25e-06	5.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—stomach cancer	3.19e-06	5.04e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—stomach cancer	3.19e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK3—stomach cancer	3.18e-06	5.02e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—stomach cancer	3.17e-06	5e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—stomach cancer	3.15e-06	4.98e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—stomach cancer	3.12e-06	4.92e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—stomach cancer	3.09e-06	4.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—stomach cancer	3.05e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—stomach cancer	3.03e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK1—stomach cancer	3.02e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—stomach cancer	3.02e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.95e-06	4.66e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—stomach cancer	2.92e-06	4.61e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.86e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.79e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—stomach cancer	2.77e-06	4.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—stomach cancer	2.71e-06	4.29e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.66e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—stomach cancer	2.65e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.62e-06	4.14e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—stomach cancer	2.54e-06	4.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—stomach cancer	2.51e-06	3.96e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.43e-06	3.83e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—stomach cancer	2.32e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.3e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—stomach cancer	2.23e-06	3.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—stomach cancer	2.13e-06	3.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—stomach cancer	2.04e-06	3.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—stomach cancer	1.71e-06	2.69e-05	CbGpPWpGaD
